Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Head & Neck 3Gynecologic 2Breast 2Plasma cell 1Other neoplasm 1Dermatologic 1Classical hematology 1

Conditions

Breast Neoplasms 2

Interventions

Cyclophosphamide 423Trastuzumab 414Paclitaxel 375Docetaxel 314Capecitabine 266Letrozole 262Carboplatin 257Doxorubicin 213Tamoxifen 184Fulvestrant 176Epirubicin 176Radiotherapy 171Anastrozole 164pembrolizumab 152pertuzumab 147Surveys and Questionnaires 146Exercise 142exemestane 128Vinorelbine 127palbociclib 124Bevacizumab 123Magnetic Resonance Spectroscopy 120Blood Specimen Collection 120Drug Therapy 106Albumin-Bound Paclitaxel 105Gemcitabine 99130-nm albumin-bound paclitaxel 98pyrotinib 92eribulin 90Biopsy 88

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Spectrometry, Fluorescence × Breast × Clear all
NCT00214292 2016-01-29

Evaluation of Breast Cancer Surgical Margins Using Optical Spectroscopy

University of Wisconsin, Madison

Phase NA Completed
20 enrolled
Breast

Breast Neoplasms

NCT00918216 2014-07-16

Spectroscopy of Breast Tissue

Case Comprehensive Cancer Center

Completed
141 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡